Ph. II candidate for met. H&N cancer
from SBDD of endogenous ligand
Clin. Cancer Res.
Aduro (Chinook Therapeutics)
MIW815 (ADU-S100) is a first-in-class STING agonist for cancer immunotherapy. Agonism of the STING (stimulator of IFN genes) receptor, true to its name, leads to stimulation of type I…